Teladoc officer plans sale of 9,812 shares

An officer of Teladoc Health filed a Rule 144 notice to potentially sell 9,812 shares of TDOC common stock through a broker.

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) is the issuer for a planned sale of common stock reported under Rule 144 by officer Fernando Madeira Rodrigues. The notice covers up to 9,812 shares of common stock, to be sold through Fidelity Brokerage Services LLC.

The filing also lists prior sales of Teladoc common stock by Fernando Madeira Rodrigues during the past three months, including transactions on June 3, 2026 and September 2, 2026, with total reported proceeds in the tens of thousands of dollars.

Key Figures

Proposed shares to be sold under Rule 144: 9,812 shares Shares sold on June 3, 2026: 9,572 shares Proceeds from June 3, 2026 sale: $70,832.80 +4 more

7 metrics

Proposed shares to be sold under Rule 144 9,812 shares Common stock covered by the Form 144 notice

Shares sold on June 3, 2026 9,572 shares Past 3 months sales table for Teladoc common stock

Proceeds from June 3, 2026 sale $70,832.80 Reported sale of 9,572 shares of common stock

Shares sold on September 2, 2026 5,439 shares Past 3 months sales table for Teladoc common stock

Proceeds from September 2, 2026 sale $34,272.77 Reported sale of 5,439 shares of common stock

Acquisition date of shares to be sold September 1, 2026 Restricted stock vesting date for the 9,812 shares

Notice date September 3, 2026 Date associated with the Form 144 remarks/signature

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact, compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 09/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Fernando Madeira Rodrigues"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

compensation financial

"9812 | 09/01/2026 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Teladoc Health (TDOC)?

It discloses that officer Fernando Madeira Rodrigues filed a Rule 144 notice for a potential sale of up to 9,812 shares of Teladoc Health common stock through Fidelity Brokerage Services LLC, with the shares acquired via restricted stock vesting on September 1, 2026.

How many Teladoc Health (TDOC) shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of up to 9,812 shares of Teladoc Health common stock. These shares are listed as acquired on September 1, 2026 through Restricted Stock Vesting and may be sold as compensation transactions.

Which broker is handling the potential Rule 144 sale for TDOC shares?

The proposed Rule 144 sale of Teladoc Health common stock is to be executed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The filing lists Fidelity as the broker for the 9,812 shares covered by the notice.

What prior Teladoc Health (TDOC) stock sales are reported in the last three months?

The filing reports two past sales by Fernando Madeira Rodrigues: on June 3, 2026, 9,572 shares of common stock were sold for $70,832.80, and on September 2, 2026, 5,439 shares were sold for $34,272.77.

Who is the person selling Teladoc Health (TDOC) shares under this Form 144?

The person is Fernando Madeira Rodrigues, identified as an officer of Teladoc Health, Inc. The Form 144 is signed by Jennifer Ruchti as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Fernando Madeira Rodrigues.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 11:46 AM EDT Accepted by SEC EDGAR 09/03/2026 - 11:45 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002037547
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	Rodrigues Fernando M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	9812	63876.12	181684021	09/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock Vesting	Issuer			9812	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Fernando Madeira Rodrigues 155 E 44th Street Suite 1700 New York NY 10017	Common	06/03/2026	9572	70832.80
Fernando Madeira Rodrigues 155 E 44th Street Suite 1700 New York NY 10017	Common	09/02/2026	5439	34272.77

144: Remarks and Signature

Remarks
Date of Notice	09/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Fernando Madeira Rodrigues
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)